Chikungunya is a virus (CHIKV) spread by bites from infected mosquitoes. Outbreaks have occurred in most areas of the world, including the Americas, Asia, Africa, Europe, ...

IRISH holidaymakers heading to a European sunshine spot this summer have been warned over new cases of a deadly “mosquito” ...

The U.S. Food and Drug Administration on Thursday approved the first vaccine against chikungunya virus, a disease that is primarily transmitted to people through infected mosquito bites. The ...

The chikungunya virus spreads to humans through mosquito bites and contact with blood. It is rarely fatal, but the symptoms can be long-lasting. Learn more here.

Chikungunya, an illness caused by a virus spread via mosquito bites but not by person-to-person contact, was first detected in the Americas near the end of 2013 as it swiftly spread to other ...

Chikungunya virus (CHIKV) causes an acute febrile disease characterized by severe arthralgia in the small joints. This arthralgia is highly debilitating and can be chronic.

The virus-like particle chikungunya vaccine received accelerated approval from the FDA in February, and is one of two single-dose vaccines to prevent disease caused by the chikungunya virus.

The Ixchiq vaccination, developed by Valneva to prevent the mosquito-borne chikungunya virus, was approved by the Food and Drug Administration (FDA) in November 2023 as the first of its kind.

Thanks to a clever modification of the baculovirus, vaccines can now be produced in insect cells more easily and cleaner. Researchers at Wageningen ...

Irish tourists have been warned to be vigilant if travelling to Europe this summer as serious viruses such as yellow fever ...

The virus-like particle chikungunya vaccine received accelerated approval from the FDA in February, and is one of two single-dose vaccines to prevent disease caused by the chikungunya virus.